Description

SOSUM H is a firm, high-density cross-linked hyaluronic acid dermal filler developed for professional correction of deeper facial wrinkles and applications requiring greater structural support. It contains 20 mg/ml hyaluronic acid and is normally supplied as two 1 ml prefilled syringes.

The “H” formulation has the firmest gel profile and largest published particle size in the standard SOSUM S, M and H range. Product selection and administration must only be undertaken by an appropriately qualified healthcare professional following an individual assessment.

What is SOSUM H?

SOSUM H is a professional dermal filler manufactured in South Korea by JSBIO Co., Ltd. Its cross-linked hyaluronic acid gel has a firm, high-viscosity profile commercially positioned for deeper correction, facial volume and contour support.

The standard box contains two individual 1 ml syringes, giving a total product volume of 2 ml. The standard CE presentation is commonly supplied without lidocaine, although professionals should always verify the ingredient information on the supplied packaging.

SOSUM H is an injectable professional product. It is not a topical cosmetic, general skincare product or a product suitable for self-administration.

SOSUM H product specifications

• Product name: SOSUM H
• Product type: Cross-linked hyaluronic acid dermal filler
• Hyaluronic acid concentration: 20 mg/ml
• Individual syringe volume: 1 ml
• Pack size: Two prefilled syringes
• Total product volume: 2 ml
• Gel profile: Firm, high-density formulation
• Published particle size: Average greater than 1,100 μm
• Lidocaine: Standard CE presentation is commonly supplied without lidocaine
• Manufacturer: JSBIO Co., Ltd.
• Country of origin: South Korea
• Published storage range: 2–25°C
• Published shelf life: Two years
• Intended user: Appropriately qualified healthcare professionals

Key characteristics of SOSUM H

SOSUM H combines a high-density gel profile with cross-linked hyaluronic acid at 20 mg/ml. The manufacturer identifies it as the firmest formulation in the standard SOSUM range.

Its published average particle size is greater than 1,100 μm. This differentiates it from the smaller-particle S formulation and the medium M formulation. Particle size and density should not be interpreted as administration instructions.

Professionals should select the product according to the patient’s anatomy, tissue characteristics, medical history and intended treatment objectives. A website description cannot establish whether SOSUM H is suitable for a particular person or application.

Cross-linked hyaluronic acid

Hyaluronic acid occurs naturally within human tissue. In professional dermal fillers, cross-linking creates a structured gel intended to provide temporary physical volume and support.

SOSUM H contains 20 mg/ml cross-linked hyaluronic acid of non-animal origin. It should not be confused with non-cross-linked skin boosters or topical hyaluronic acid products.

Individual outcomes and duration can vary depending on the treatment area, quantity, technique, tissue characteristics and patient metabolism. No precise outcome or fixed duration should be promised.

SOSUM H compared with S and M

The standard SOSUM collection includes three gel profiles:

• SOSUM S: Soft, small-particle formulation commercially positioned for fine and superficial correction.
• SOSUM M: Medium-density formulation intended to balance flexibility and structural support.
• SOSUM H: Firm, large-particle formulation intended for deeper correction and applications requiring greater support.

The letters describe different gel characteristics rather than package sizes. All three standard products are commonly supplied as two 1 ml syringes, but they should not be treated as interchangeable.

Manufacturing and purification

Published product information describes the use of Low-Temperature Stabilisation Reaction technology to cross-link the hyaluronic acid. The range is also described as undergoing a two-stage purification process.

These manufacturing features must not be used to claim that the product is free from all risks, allergic reactions or complications. Any injectable filler requires appropriate patient selection, professional technique and preparation for possible adverse events.

The label, instructions for use and documentation supplied with the actual product should always take priority over general information found online.

Professional consultation and suitability

SOSUM H must only be administered by a healthcare professional with suitable qualifications, training, insurance and legal authority. It must not be self-injected, used at home or administered by an untrained person.

A consultation should review relevant medical conditions, medication, allergies, previous filler treatments, existing implants, skin condition and treatment expectations. The practitioner should identify contraindications and determine whether another product or procedure would be more appropriate.

Potential risks, complications, alternatives and aftercare should be explained before treatment. Patients should be told how to obtain urgent professional assistance if they experience unexpected or concerning symptoms.

Packaging and authenticity checks

Inspect every SOSUM H box before professional use. Confirm the complete product name, two-syringe pack size, 20 mg/ml concentration, batch number, expiry date and condition of the packaging.

Do not use a syringe if its sterile barrier is damaged, leaking, previously opened or altered. Products that cannot be authenticated or whose storage history is unknown should not be administered.

Retain the invoice, box and batch details for traceability. Check the ingredient panel for lidocaine and ensure that your product description accurately reflects the supplied formulation.

Storage and responsible handling

Published product information recommends storing SOSUM H in a cool location away from direct sunlight, commonly between 2°C and 25°C. Follow the instructions on the supplied packaging if they differ.

Keep the syringes sealed and protected from unauthorised access. Each syringe is intended for single-patient professional use and must be disposed of according to relevant infection-control, sharps and clinical-waste requirements.

Important regulatory information

This description provides general commercial information only. It is not medical advice, an injection protocol or confirmation that SOSUM H is authorised for every treatment area or jurisdiction.

Purchasers are responsible for establishing whether the product can legally be imported, supplied and used for their intended purpose. Practitioners must follow the instructions and regulations applicable to their specific product and location.

For manufacturer information, visit the official SOSUM H product page. You can also browse professional products available from The Clinic Vault shop.

Order SOSUM H

Each standard box contains two 1 ml prefilled syringes, providing a total product volume of 2 ml. Before ordering, confirm that the high-density H formulation and non-lidocaine presentation match your professional requirements.

Add SOSUM H to your basket when ready, or contact The Clinic Vault for clarification about packaging or availability. This product is intended for qualified healthcare professionals and must not be self-administered.